Skip to main content
BDMD
NASDAQ Industrial Applications And Services

Baird Medical Files Full Terms of $4.35M Convertible Note with 92% VWAP Discount Conversion

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.78
Mkt Cap
$24.962M
52W Low
$0.661
52W High
$3.7
52W Position info
18% above low
Off High info
79% below high
Rel. Volume info
1.1× avg
Market data snapshot near publication time

BDMD sits 18% above its 52-week low of $0.661.

Summary

Baird Medical filed the full terms of a $4.35 million senior secured convertible note with a 92% VWAP discount conversion feature, a pledge of its U.S. subsidiary, and a first-priority lien on U.S. assets — terms that heavily favor the investor.


Key Events · Financing and Capital Events · BDMD

  • Convertible Note Terms Disclosed

    The company issued a senior 8% original issue discount convertible note with a principal amount of $4,347,826 for a $4,000,000 subscription amount. The note converts at the lower of $0.9842 (120% of the three-day VWAP before closing) or 92% of the lowest daily VWAP over the seven trading days before conversion (85% upon default).

  • Investor Identified

    The investor is L1 Capital Global Opportunities Master Fund, a Cayman Islands exempted company. The investor has the obligation to lend an additional $3,680,000 within 180 days and up to $6 million more within 360 days, subject to conditions including a closing price above $1.00.

  • Secured by U.S. Assets and Subsidiary Equity

    The note is secured by a first-priority perfected security interest in substantially all U.S. assets of the company and Baird Medical LLC, plus a pledge of all equity interests of Baird Med LLC. All subsidiaries except two excluded entities guarantee the note.

  • Pre-Delivery and Discount Shares

    The company issued 1,500,000 Pre-Delivery Shares to facilitate conversions and 110,070 Discount Shares at $0.79 per share for the additional 2% original issue discount. The investor is subject to a 9.99% beneficial ownership limitation.


Analysis · BDMD · Industrial Applications And Services

The complete Securities Purchase Agreement for a $4.35 million senior secured convertible note has been filed, and the terms heavily favor the investor. Conversion occurs at the lower of $0.9842 or 92% of the lowest daily VWAP over the prior seven trading days — a structure that lets the investor convert at a discount to market and sell into any strength. The company also pledged its U.S. operating subsidiary's equity and granted a first-priority lien on substantially all U.S. assets, meaning the investor has a claim on the company's core assets ahead of other creditors. This comes just days after the company disclosed a going-concern assessment resolved only through a $2.0 million support letter from its CEO, and follows a $27.5 million annual loss with just $0.2 million in cash. The financing keeps the company alive but at the cost of severe potential dilution and a senior secured claim on its assets.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDMD was trading at $0.78 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $25M. The 52-week trading range was $0.66 to $3.70. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDMD - Latest Insights

BDMD
Nov 16, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0924
Real-time Price: $0.0812 info
Change: -$0.0112 (-12%) info
Market Cap: $2.627M info
BDMD
Nov 04, 2026, 4:45 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1034
Real-time Price: $0.0812 info
Change: -$0.0222 (-21%) info
Market Cap: $2.627M info
BDMD
Nov 02, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1502
Real-time Price: $0.0812 info
Change: -$0.069 (-46%) info
Market Cap: $2.627M info
BDMD
Sep 30, 2026, 7:18 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7725
Real-time Price: $0.0812 info
Change: -$0.6913 (-89%) info
Market Cap: $2.627M info
BDMD
Sep 24, 2026, 4:05 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.760
Real-time Price: $0.0812 info
Change: -$0.6788 (-89%) info
Market Cap: $2.627M info